Figure 3.
Spectrum of CH in age-related CH compared with the germ line RUNX1 carriers-without HM cohort. (A) Prevalence of CH in the control population compared with the germ line RUNX1 carriers-without HM cohort. The control population includes cohorts from Jaiswal et al32 and Genovese et al33 (n = 27 783). The 0 to 18 age group is only available for the RUNX1 cohort. (B) Mutational spectrum of CH in the control population compared with the germ line RUNX1 carriers-without HM cohort. Graph shows the frequency of variants in individuals with CH in each cohort. The control population includes cohorts from Desai et al,36 Abelson et al,35 and Jaiswal et al.32 ∗P < .05, ∗∗P < .001, 2-proportions Z test, approximate to normal distribution, ±95% confidence interval.

Spectrum of CH in age-related CH compared with the germ line RUNX1 carriers-without HM cohort. (A) Prevalence of CH in the control population compared with the germ line RUNX1 carriers-without HM cohort. The control population includes cohorts from Jaiswal et al32 and Genovese et al33 (n = 27 783). The 0 to 18 age group is only available for the RUNX1 cohort. (B) Mutational spectrum of CH in the control population compared with the germ line RUNX1 carriers-without HM cohort. Graph shows the frequency of variants in individuals with CH in each cohort. The control population includes cohorts from Desai et al,36 Abelson et al,35 and Jaiswal et al.32P < .05, ∗∗P < .001, 2-proportions Z test, approximate to normal distribution, ±95% confidence interval.

Close Modal

or Create an Account

Close Modal
Close Modal